A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose of the oral Src/Abl
inhibitor AZD0424, and to find tolerable and effective AZD0424 combination regimens for the
treatment of advanced solid tumours